The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
1. Discussion of overall implications of pharmacy issues
2. Impact of manufacturers on CHCs and the risk to the CHC program as a whole
3. Strategy for moving forward
4. Split billing and compliance strategy
5. Legislative updates
6. Q&A
Learning Objectives
Develop plan for assessing impact and risk of the actions of manufacturers.
Learn how to run and manage a compliant and success 340B program.
Understand the financial impact of the 340B program and develop options to overcome barriers.
Too often, finance and quality teams speak a different language in terms of “value” – e.g., productivity vs health outcomes. This panel presents a framework that assesses strategic plans and priority projects in the context of maximized value…
CMS, State Medicaid programs and commercial payers are getting more aggressive in moving providers from volume to value-based pay (VBP). Exactly how VBP will be implemented is evolving, particularly for FQHCs, but it does appear to be here to stay…
Childhood immunizations is a UDS measure on which is notoriously difficult to improve. The change in the age cut-off for the measure from 3 to 2 years along with persistent cultural and social factors surrounding vaccinations has made this measure a challenge for community health centers…
COVID-19 has resulted in additional funding for Health Centers. As frequently happens with new federal funding the compliance environment evolves with the latest frequently asked question (FAQ) updates, new reporting guidelines and documentation standards…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.